NH

Nileshdattatray Hodarkar

Active Director Director DIN 08021179
DIN 08021179 First appointment Dec 2017 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Nileshdattatray Hodarkar

Data last updated:

Nileshdattatray Hodarkar is a Director at Nigarva Pharmaceuticals India Private Limited (since 2017). The company operates in Food And Beverages.

DIN 08021179
Primary Designation Director
Industry Food And Beverages
First Appointment 28 Dec 2017
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Dec 20172017Active

Directorship timeline

Open interactive timeline →
Nigarva Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Nileshdattatray Hodarkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nileshdattatray Hodarkar

Nileshdattatray Hodarkar currently holds 1 directorship: Nigarva Pharmaceuticals India Private Limited (Director, since 28 Dec 2017).

Nileshdattatray Hodarkar was first appointed on 28 Dec 2017 as Director at Nigarva Pharmaceuticals India Private Limited.

The current boards of Nileshdattatray Hodarkar's companies include Gaurish Jaiwant Sawant (Nigarva Pharmaceuticals India Private Limited), Rajesh Baburao Kapolkar (Nigarva Pharmaceuticals India Private Limited), Vaibhav Vaman Kalangutkar (Nigarva Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available